•  
  •  
  •  
  •  

2026-01-09 17:50:58

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Beezaasan Explotech Ltd completes export order successfully
  • WeWork India crosses 1 lakh members, reinforcing its leadership in the flexible workspace sector
  • KAKA Industries Limited - Business Update - Q3 FY 2025-26
  • Nifty Slips for Third Straight Session, Showed Resilience with Late Bounce back
  • ACS Technologies Ltd receives order from Mahindra Defence Systems Ltd

Keywords Selected:  Dasatinib

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Zydus receives approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg
  • Lupin receives tentative approval from U.S. FDA for Dasatinib Tablets
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Dasatinib Tablets

Latest Post

  • Beezaasan Explotech Ltd completes export order successfully
  • WeWork India crosses 1 lakh members, reinforcing its leadership in the flexible workspace sector
  • KAKA Industries Limited - Business Update - Q3 FY 2025-26
  • Nifty Slips for Third Straight Session, Showed Resilience with Late Bounce back
  • ACS Technologies Ltd receives order from Mahindra Defence Systems Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025